DE86122T1 - Zusammensetzung zur tumorumkehrung und ihre verwendung in der krebsforschung. - Google Patents
Zusammensetzung zur tumorumkehrung und ihre verwendung in der krebsforschung.Info
- Publication number
- DE86122T1 DE86122T1 DE198383400095T DE83400095T DE86122T1 DE 86122 T1 DE86122 T1 DE 86122T1 DE 198383400095 T DE198383400095 T DE 198383400095T DE 83400095 T DE83400095 T DE 83400095T DE 86122 T1 DE86122 T1 DE 86122T1
- Authority
- DE
- Germany
- Prior art keywords
- composition
- polyethylene glycol
- reverse
- tumor
- theophylline
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims 4
- 206010028980 Neoplasm Diseases 0.000 title 1
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims 4
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 claims 4
- 239000002202 Polyethylene glycol Substances 0.000 claims 3
- 229920001223 polyethylene glycol Polymers 0.000 claims 3
- 238000006243 chemical reaction Methods 0.000 claims 2
- 239000003795 chemical substances by application Substances 0.000 claims 2
- 229960000278 theophylline Drugs 0.000 claims 2
- 210000004881 tumor cell Anatomy 0.000 claims 2
- 239000004480 active ingredient Substances 0.000 claims 1
- 239000002671 adjuvant Substances 0.000 claims 1
- 239000012153 distilled water Substances 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8201397A FR2520619A1 (fr) | 1982-01-29 | 1982-01-29 | Composition revertante basee sur l'association polyethylene glycol-dimethylsulfoxyde-theophylline et son emploi en cancerologie |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE86122T1 true DE86122T1 (de) | 1983-11-24 |
Family
ID=9270449
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE198383400095T Pending DE86122T1 (de) | 1982-01-29 | 1983-01-14 | Zusammensetzung zur tumorumkehrung und ihre verwendung in der krebsforschung. |
| DE8383400095T Expired DE3370283D1 (en) | 1982-01-29 | 1983-01-14 | Composition for tumour reversion and its use in cancerology |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE8383400095T Expired DE3370283D1 (en) | 1982-01-29 | 1983-01-14 | Composition for tumour reversion and its use in cancerology |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US4767763A (en, 2012) |
| EP (1) | EP0086122B1 (en, 2012) |
| JP (1) | JPS58146510A (en, 2012) |
| CA (1) | CA1188226A (en, 2012) |
| DE (2) | DE86122T1 (en, 2012) |
| FR (1) | FR2520619A1 (en, 2012) |
| IL (1) | IL67748A (en, 2012) |
| ZA (1) | ZA83396B (en, 2012) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9417742D0 (en) * | 1994-09-03 | 1994-10-19 | Univ Nottingham | Macrophage stimulating composition |
| JP2008308473A (ja) * | 2007-06-18 | 2008-12-25 | Japan Health Science Foundation | 癌治療剤 |
| FR3012037B1 (fr) * | 2013-10-23 | 2016-05-20 | Herve Edouard Henri Jeambourquin | Solution révertante à base de diméthylsulfoxyde et de polyéthylène-glycol |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA824650A (en) * | 1969-10-07 | Desjardins Roger | Suppository | |
| GB1043012A (en) * | 1964-07-28 | 1966-09-21 | Ici Ltd | Pharmaceutical compositions comprising tumour-growth-inhibitory agents |
-
1982
- 1982-01-29 FR FR8201397A patent/FR2520619A1/fr active Granted
-
1983
- 1983-01-14 DE DE198383400095T patent/DE86122T1/de active Pending
- 1983-01-14 DE DE8383400095T patent/DE3370283D1/de not_active Expired
- 1983-01-14 EP EP83400095A patent/EP0086122B1/fr not_active Expired
- 1983-01-19 CA CA000419788A patent/CA1188226A/en not_active Expired
- 1983-01-20 ZA ZA83396A patent/ZA83396B/xx unknown
- 1983-01-25 IL IL67748A patent/IL67748A/xx not_active IP Right Cessation
- 1983-01-28 JP JP58011585A patent/JPS58146510A/ja active Granted
-
1986
- 1986-07-07 US US06/883,300 patent/US4767763A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JPS58146510A (ja) | 1983-09-01 |
| DE3370283D1 (en) | 1987-04-23 |
| IL67748A (en) | 1986-01-31 |
| EP0086122B1 (fr) | 1987-03-18 |
| EP0086122A1 (fr) | 1983-08-17 |
| IL67748A0 (en) | 1983-05-15 |
| CA1188226A (en) | 1985-06-04 |
| FR2520619B1 (en, 2012) | 1984-04-06 |
| FR2520619A1 (fr) | 1983-08-05 |
| US4767763A (en) | 1988-08-30 |
| JPH0460093B2 (en, 2012) | 1992-09-25 |
| ZA83396B (en) | 1983-10-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Carbajal et al. | Pharmacological study of Cymbopogon citratus leaves | |
| EP0176033A3 (de) | Isoxazolcarbonsäure-Derivate, ihre Herstellung und Verwendung | |
| DE3741420C2 (de) | Lichtstabiles kosmetisches Mittel zum Schutz der Humanepidermis und Verfahren zur Stabilisierung von 4-(1,1-Dimethylethyl )-4'-methoxydibenzoylmethan gegen UV-Bestrahlung | |
| EP0026464A3 (de) | Peptide, deren Herstellung, deren Verwendung und pharmazeutische Präparate | |
| PT84078A (de) | Dyarylalkyl-substituierte alkylamine verfahren zu ihrer herstellung ihre verwendung sowie sie enthaltende arzneimittel | |
| DE19675017I2 (de) | Neue Derivate der 3-Aminopropansulfonsaeure diese enthaltende Arzneimittel sowie Verfahren zu ihrer Herstellung | |
| DE3438455A1 (de) | L-lysin- und l-histidinpyruvat | |
| EP0079556A3 (de) | Morphinanderivate, ihre Herstellung, sowie diese enthaltende Arzeimittel | |
| EP0257485A3 (de) | Kombination von positiv inotrop wirkenden Dihydropyridinen mit ACE-Hemmern, sowie ihre Verwendung in Arzneimitteln | |
| ATE95070T1 (de) | Pharmazeutische zusammensetzung mit gehalt an einer mischung von kollagen und einem antiseptischen und/oder entzuendungshemmenden wirkstoff und verfahren zu ihrer herstellung. | |
| DE3415413A1 (de) | Melanin-inhibitor | |
| EP0127160B1 (de) | Äusserlich anzuwendende Arzneimittelzubereitung enthaltend Adenosin zur Behandlung von Herpes | |
| AT289765B (de) | Verfahren zur Herstellung von neuen 1-(4'-Acylamino)-2-hydroxy-3-aminopropanen sowie von deren Säureadditionssalzen | |
| DE86122T1 (de) | Zusammensetzung zur tumorumkehrung und ihre verwendung in der krebsforschung. | |
| EP0078240A3 (de) | Lactone | |
| DE2504331A1 (de) | Heptaminol-5'-adenosinmonophosphat und dessen therapeutische verwendung | |
| PT74922B (de) | Substituierte tryptaminderivate von thienyloxypropanolaminen verfahren zu ihrer herstellung pharmazeutische praparate auf basis dieser verbindungen sowie ihre verwendung | |
| PT72981A (de) | Neue substituierte 2(3h)-benzothiazolone verfahren zu ihrer herstellung ihre verwendung zur herstellung von arzneimitteln und arzneimittel die diese verbindungen enthalten | |
| EP0104445A3 (de) | Piperidinochinoxalin-Derivate, ihre Herstellung und Verwendung | |
| PT69156A (de) | Neue purin-derivate verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel | |
| PT76986A (de) | Neue phenylessigsaeure-derivate ihre herstellung und diese verbindungen enthaltende arzneimittel | |
| TR21618A (tr) | Metilen-2 sueksinamik asid'in yeni tuerevleri bunlarin hazirlanmasi ve bunlari ihtiva oden bitkilerin yetismesini duezenleyici bilesimler | |
| IT1134202B (it) | Coadiuvante per promuovere l'absorbimento di sostanze farmacologicamente attive attraverso il retto,e composizione farmaceutica che lo comprendono | |
| EP0094052A3 (de) | 1-(1,3-Dioxolan-2-yl-methyl)-1H-imidazole und -1H-1,2,4-triazole und deren Salze, Verfahren zu ihrer Herstellung, sie enthaltende Mittel und ihre Verwendung | |
| DE2257285C3 (de) | Pharmazeutisches Präparat mit einem Gehalt an l^-DiphenyM-n-butyM-hydroxymethyl-S^-dioxopyrazolidinhalbsuccinat |